Exosome Antibody Development Services

Exosome antibodies are antibodies developed against surface markers of exosomes. They are important tools for researchers to characterize and diagnose exosomes, and help to study the relationship between exosomes and diseases. Traditional antibodies are generally developed for cells and are applicable to cells, while the size of exosomes is much smaller than cells, so antibodies specific to exosomes need to have stronger specificity. Most antibodies on the market currently cannot identify exosome-related antigens with sufficient sensitivity and specificity.

CD Formulation offers a range of highly specific monoclonal/polyclonal antibodies against the common (CD63、CD9、CD81, etc) and disease-specific exosomal proteins. In addition, we can also provide exosome antibody customization services, providing customers with targeted protein labeling services, serving the majority of scientific researchers.

What Exosome Antibodies We Currently Provide?

CD Formulation provides a range of highly specific monoclonal/polyclonal antibodies. If you are having difficulty selecting exosome antibodies, please feel free to contact us, and our experts will be happy to recommend suitable products to meet your needs. Our existing exosome antibodies include but are not limited to:

• Anti-CD9 mouse monoclonal Biotin-conjugated
• Anti-CD63 mouse monoclonal unconjugated
• Anti-CD81 mouse monoclonal unconjugated
• Anti-flotillin rabbit polyclonal unconjugated
• Anti-TSG101 mouse monoclonal
• Anti-CD44 mouse monoclonal unconjugated

The advantages of our exosome antibodies

• High sensitivity
• Cost-effective price
• High specificity
• Multiple applications including western blot, FACS, ELISA, IP, IHC, etc.

Exosome Antibody Development

In addition to existing exosome antibodies, we also provide exosome antibody development services. CD Formulation uses different technologies to provide high-quality exosome antibody development services, including phage display technology and B cell sorting technology, which can help the discovery of antibodies that recognize exosome-associated antigens with sufficient sensitivity and specificity. If you are interested in our services, please feel free to contact us.

Phage Display Technology for Exosome Antibody Development

Phage display technology inserts different foreign genes into phage vectors, and as the phages are passed through successive generations, the foreign proteins are displayed on the surface of the phages, forming a phage library. Subsequently, using specific proteins to screen the phage library, antibodies with high affinity for the protein can be quickly obtained. CD Formulation has a first-class preformed phage display antibody library, providing a full-process solution for phage display exosome antibody discovery, which is used to screen exosome antibodies with high specificity and affinity.

B Cell Sorting Technology for Exosome Antibody Development

B cell sorting technology is a useful approach to develop antibodies for diagnostics, pharmacokinetic studies, and clinical development. CD Formulation enables antibody screening for different exosome markers, and whether you are looking for an antibody against well-characterized exosome markers or novel candidate markers, we can customize the service to meet your specific requirements.

Our Advantages

• CD Formulation has a high-throughput antibody screening platform with fast delivery cycle.
• The exosome antibody R&D team has many years of experience in antibody development, with high product delivery standards and good antibody affinity.
• Complete upstream and downstream services, and the generated antibodies are suitable for various downstream applications.
• Experimental solutions can be customized according to customer needs, saving you valuable time and experimental funds.